logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

GYRE
Gyre Therapeutics, Inc.
6.06
1 x 5.40
1 x 8.56
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd-14.16%
1y-16.18%
6.04
day range
6.05
5.44
52 week range
9.42
Open6.05Prev Close6.06Low6.04High6.05Mkt Cap553.83M
Vol494.00Avg Vol93.84KEPS0.07P/E86.57Forward P/E25.22
Beta1.89Short Ratio21.22Inst. Own1.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg6.34200-d Avg7.371yr Est0.00

GYRE News

Gyre Therapeutics Appoints Three New Members to its Board of Directors
globenewswire.com
Gyre Therapeutics Appoints Three New Members to its Board of Directors

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or

Earnings Scheduled For March 12, 2026
benzinga.com
Earnings Scheduled For March 12, 2026

Earnings Scheduled For November 7, 2025
benzinga.com
Earnings Scheduled For November 7, 2025

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session